

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Defibrotide is a specialized intravenous medication that helps protect blood vessels and prevent dangerous clotting in your liver. It's primarily used to treat a serious condition called veno-occlusive disease (VOD), which can occur after certain cancer treatments like stem cell transplants.
This medication works by supporting your body's natural healing processes when your liver's blood vessels become damaged. While it's not a common drug you'll encounter in everyday medicine, it plays a crucial role in helping people recover from specific, life-threatening complications.
Defibrotide is a blood vessel-protecting medication given through an IV line directly into your bloodstream. It's made from natural substances found in pig intestines, which are processed to create a medicine that helps heal damaged blood vessels.
This medication belongs to a class of drugs called antithrombotic agents, which means it helps prevent harmful blood clots from forming. Unlike blood thinners you might know, defibrotide works specifically on the tiny blood vessels in your liver and other organs.
The medicine comes as a clear, colorless solution that healthcare providers prepare and administer in hospital settings. It's not something you can take at home - it requires careful monitoring by medical professionals.
Defibrotide treats veno-occlusive disease (VOD), a serious condition where small blood vessels in your liver become blocked and damaged. This typically happens after high-dose chemotherapy or stem cell transplants used to treat blood cancers.
VOD occurs when the intense cancer treatments damage the lining of tiny liver blood vessels, causing them to swell and block blood flow. Without proper treatment, this can lead to liver failure and other life-threatening complications.
The medication is specifically approved for treating severe VOD with kidney or lung problems. Your doctor will only prescribe this if you have confirmed VOD that's affecting multiple organs, not just your liver.
In some cases, doctors might use defibrotide to prevent VOD in high-risk patients, though this use is less common and depends on your specific medical situation.
People also ask
Defibrotide is specifically used to treat severe Veno-Occlusive Disease, which affects the blood vessels in the liver. It helps restore the normal function of these vessels rather than just masking the discomfort.
No, this is typically administered as a short-term intensive therapy while you are hospitalized. It is intended to stabilize the condition during a critical period of recovery.
Defibrotide works by protecting and healing the damaged lining of your blood vessels, particularly in your liver. It helps restore normal blood flow by reducing inflammation and preventing harmful clots from forming.
The medication acts on multiple pathways in your body at once. It reduces the stickiness of blood cells, decreases inflammation, and helps your blood vessels relax and open up properly.
Think of it as a multi-tool for your blood vessels - it addresses several problems simultaneously rather than just targeting one issue. This makes it particularly effective for the complex nature of VOD.
Unlike stronger blood thinners, defibrotide is considered a gentler medication that works with your body's natural healing processes. It supports recovery without dramatically altering your blood's ability to clot when needed.
Defibrotide is always given through an IV line by healthcare professionals in a hospital setting. You cannot take this medication at home - it requires continuous medical supervision and monitoring.
The typical treatment involves receiving the medication every 6 hours for at least 21 days. Your healthcare team will calculate your exact dose based on your weight and kidney function.
Each infusion takes about 2 hours to complete. During this time, you'll be closely monitored for any reactions or side effects. The IV line allows the medication to go directly into your bloodstream for maximum effectiveness.
You don't need to avoid food or drinks during treatment, but your medical team will guide you on any dietary restrictions based on your overall condition and other medications you might be taking.
People also ask
You will receive the medication through a small tube in your vein over two hours. Most people do not feel the medication itself, though the equipment might feel slightly restrictive.
You can move within the limits of your IV tubing and the infusion pump, though staying relatively still is usually best. Many people use this time to rest, read, or listen to music.
Most people receive defibrotide for a minimum of 21 days, though treatment can continue longer if needed. Your doctor will determine the exact duration based on how well you're responding to the medication.
Some patients may need treatment for several weeks or even months, depending on the severity of their condition and how quickly their blood vessels heal. Your medical team will regularly assess your progress through blood tests and imaging studies.
The goal is to continue treatment until your VOD shows clear signs of improvement and your organ function stabilizes. Your doctor will look for specific markers in your blood and improvements in your symptoms before considering stopping the medication.
It's important to complete the full course of treatment even if you start feeling better. Stopping too early could allow the condition to worsen again.
Like all medications, defibrotide can cause side effects, though not everyone experiences them. The most common side effects are generally mild and manageable with proper medical care.
Here are the side effects you might experience, grouped by how commonly they occur:
Common side effects (affecting more than 1 in 10 people):
Less common but notable side effects:
Serious but rare side effects:
Your healthcare team will monitor you closely for these effects and can manage most of them effectively. They'll adjust your treatment or provide additional medications if needed to keep you comfortable.
People also ask
The most frequent concern is an increased risk of bleeding, as the medication affects how your blood flows. Medical teams manage this by performing frequent checks to catch any changes early.
Most side effects are linked to the time the medicine is active in your system and tend to fade quickly once the course is complete. A few people may feel lingering fatigue as their body recovers from the illness.
Defibrotide isn't suitable for everyone, and your doctor will carefully evaluate whether it's safe for you. People with certain medical conditions or those taking specific medications may not be able to use this treatment.
You should not receive defibrotide if you have active, uncontrolled bleeding anywhere in your body. This includes internal bleeding, recent surgery with ongoing bleeding, or bleeding disorders that can't be managed.
People with severe kidney problems may need dose adjustments or might not be candidates for this medication. Your doctor will check your kidney function before starting treatment.
If you're pregnant or breastfeeding, the risks and benefits need careful consideration. While there's limited data on defibrotide's effects during pregnancy, your doctor will only recommend it if the benefits clearly outweigh the risks.
Certain medications can interact with defibrotide, particularly other blood thinners or medications that affect blood clotting. Your healthcare team will review all your medications before starting treatment.
Defibrotide is primarily available under the brand name Defitelio in most countries, including the United States and Europe. This is the most commonly recognized name for this medication.
Some regions may have different brand names or generic versions available, but Defitelio remains the primary brand used in major medical centers worldwide.
Your healthcare team will handle the ordering and preparation of this medication, so you don't need to worry about finding specific brands or formulations.
Currently, there are no direct alternatives to defibrotide for treating severe veno-occlusive disease. It's the only medication specifically approved for this condition.
Before defibrotide became available, doctors used supportive care measures like managing fluid balance, controlling blood pressure, and supporting organ function. These approaches are still important but aren't as effective as defibrotide for treating VOD.
Some doctors might try other medications off-label, such as certain blood thinners or anti-inflammatory drugs, but these haven't shown the same level of effectiveness as defibrotide.
Research is ongoing into new treatments for VOD, but for now, defibrotide remains the gold standard for treating this serious condition.
Defibrotide is uniquely designed for treating veno-occlusive disease, making it difficult to compare directly with other blood vessel medications. It's not necessarily "better" than other drugs, but rather specifically suited for a particular condition.
Unlike general blood thinners like heparin or warfarin, defibrotide works specifically on damaged blood vessel linings. This targeted approach makes it more effective for VOD than broader-acting medications.
The medication's ability to work on multiple pathways simultaneously - reducing inflammation, preventing clots, and promoting healing - sets it apart from single-action drugs.
For treating VOD, clinical studies have shown defibrotide to be significantly more effective than supportive care alone, with improved survival rates and faster recovery times.
Is Defibrotide Safe for People with Heart Disease?
Defibrotide can be used in people with heart disease, but it requires extra monitoring and care. Your heart condition will be carefully evaluated before starting treatment.
The medication can affect blood pressure and heart rhythm, so your healthcare team will monitor your heart function closely during treatment. They may adjust the dose or infusion rate based on how your heart responds.
Having heart disease doesn't automatically prevent you from receiving defibrotide if you need it for VOD. Your doctors will weigh the risks and benefits carefully and provide appropriate monitoring.
What Should I Do if I Experience Severe Side Effects?
If you experience severe side effects like difficulty breathing, severe bleeding, or chest pain, notify your healthcare team immediately. Since you're in the hospital during treatment, help is always nearby.
Your medical team is trained to recognize and manage serious side effects quickly. They may temporarily stop the infusion, adjust your dose, or provide additional medications to manage the reaction.
Don't hesitate to report any concerning symptoms, even if they seem minor. Early intervention can prevent more serious complications and keep you safer during treatment.
What Should I Do if a Dose is Missed?
Since defibrotide is given in a hospital setting, missed doses are rare. If a dose is delayed for medical reasons, your healthcare team will adjust the schedule accordingly.
The medication works best when given on a regular schedule, so your medical team will work to maintain consistent timing. If a dose must be delayed, they'll determine the best approach for continuing treatment.
You don't need to worry about managing the medication schedule yourself - your healthcare team handles all timing and dosing decisions.
When Can I Stop Taking Defibrotide?
You can stop taking defibrotide when your doctor determines that your veno-occlusive disease has improved sufficiently and your organ function has stabilized. This decision is based on blood tests, imaging studies, and your overall clinical improvement.
Most people complete at least 21 days of treatment, but some may need longer courses depending on their response. Your doctor will monitor specific markers that indicate whether the treatment is working.
Never stop the medication on your own, even if you feel better. VOD can worsen quickly if treatment is stopped too early, so it's important to complete the full course your doctor recommends.
Can I Take Other Medications While on Defibrotide?
Some medications can be safely taken with defibrotide, while others may need to be avoided or adjusted. Your healthcare team will review all your medications before starting treatment.
Blood thinners and certain pain medications may need special consideration since they can increase bleeding risk when combined with defibrotide. Your doctors will manage these interactions carefully.
Always inform your healthcare team about any new medications, supplements, or over-the-counter drugs you want to take during treatment. They can advise you on safety and any necessary adjustments.
Get clear medical guidance
on symptoms, medications, and lab reports.
Download August today. No appointments. Just answers you can trust.